Clinical Trials
136
Active:6
Completed:43
Trial Phases
4 Phases
Phase 1:26
Phase 2:37
Phase 4:13
+1 more phases
Drug Approvals
2
FDA:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (118 trials with phase data)• Click on a phase to view related trials
Not Applicable
42 (35.6%)Phase 2
37 (31.4%)Phase 1
26 (22.0%)Phase 4
13 (11.0%)Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Not Applicable
Not yet recruiting
- Conditions
- Hepatopancreaticobiliary (HPB) MalignancyBladder CancerOvarian Cancer (OvCa)Kidney Cancers
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 148
- Registration Number
- NCT07050771
Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment
Completed
- Conditions
- Carotid Endarterectomy (CEA) Surgical Patients
- First Posted Date
- 2025-07-02
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 500
- Registration Number
- NCT07048067
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Stem Cells for Erectile Dysfunction Post RALP
Not Applicable
Not yet recruiting
- Conditions
- Erectile DysfunctionProstate Cancer
- Interventions
- Drug: Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the ORDrug: Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's officeDrug: Placebo in clinicDrug: Placebo in the OR
- First Posted Date
- 2025-07-02
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT07048314
- Locations
- 🇺🇸
Houston Methodist, Houston, Texas, United States
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
Not Applicable
Not yet recruiting
- Conditions
- Metastatic Colorectal Cancer (CRC)
- Interventions
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT07042685
- Locations
- 🇺🇸
Houston Methodist Neal Cancer Center, Houston, Texas, United States
Surgical Site Infection Outcomes in Natural Orifice Intracorporeal Anastomosis and Extraction (NICE) Procedure - The NICE Trial
- Conditions
- DiverticulitisSurgical Site InfectionSurgical Site InfectionsColorectal SurgeryRobotic Surgical ProceduresClinical TrialsDiverticulitis, ColonicDiverticulitis ColonDiverticulitis; Perforation, Bowel
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 300
- Registration Number
- NCT06957236
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 28
- Next
News
No news found